(CDLX) Cardlytics - Ratings and Ratios

Cardlytics, Inc. is a pioneering advertising platform operator in the US and UK, leveraging its proprietary technology to enable marketers to reach customers through various digital channels. The companys flagship product, the Cardlytics platform, is a native bank advertising channel that utilizes real-time data to deliver targeted advertisements. Additionally, its Bridg platform is a customer data platform that harnesses point-of-sale data from merchant partners, providing marketers with actionable insights to optimize their loyalty marketing strategies and measure campaign effectiveness.

By integrating purchase data with digital marketing, Cardlytics offers a unique value proposition to its clients. The companys ability to provide product-level purchase data enables marketers to tailor their campaigns with unprecedented precision. With its headquarters in Atlanta, Georgia, Cardlytics has established itself as a key player in the advertising technology space since its inception in 2008.

Analyzing the , we observe that the stock has been trending upwards in the short term, with the SMA20 and SMA50 at $1.80 and $1.84, respectively. However, the SMA200 at $3.25 indicates a significant drop in the stocks value over the past year. The ATR of 0.20 represents a 9.91% volatility, suggesting a relatively high level of price fluctuation. Considering the , the companys Market Cap stands at $113.22M USD, with a negative P/E ratio indicating unprofitability. The RoE of -137.96 further highlights the companys current financial struggles.

Based on the and , a forecast for Cardlytics Inc. (CDLX) can be derived. While the short-term trend is positive, the long-term trend is concerning. If the company can address its profitability issues and improve its financials, the stock may experience a significant rebound. A potential target price could be around $4.50, representing a 118% increase from the current price of $2.06. However, this is contingent upon the companys ability to demonstrate substantial growth and improve its financial metrics. Until then, the stock remains a high-risk investment.